Article
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Clinical Trial Designs for Topical Antifungal Treatments of Onychomycosis and Implications on Clinical Practice
- Author:
- Phoebe Rich, MD
- Tracey C. Vlahovic, DPM
- Warren S. Joseph, DPM
- Lee T. Zane, MD
- Steve B. Hall, PharmD
- Nicole Gellings Lowe, PhD
- Chris G. Adigun, MD
There currently are 3 topical agents approved by the US Food and Drug Administration (FDA) to treat onychomycosis: tavaborole, efinaconazole, and...